aod9604 igf1 levels study AOD-9064 Fat-Metabolizing Peptide Fragment WHAT IT IS • Synthetic fragment of human growth hormone • Targets the fat-burning domain only • Does not significantly increase IGF-1 or affect glucose • Designed for Safety and Tolerability of the

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

targeted NNMT knockdown protected against DIO by increasing energy expenditure

A., Taher, I., Abubaker, J

For weight loss, the effects are typically seen over time, especially when combined with a healthy diet and exercise routine

Formulations of cyanocobalamin injection containing benzyl alcohol as a preservative should also be avoided in premature neonates and those with hypersensitivity due to its association with gasping syndrome (10-12)

You will need to replace the needle before you try again